Montagna, D. R., Duarte, A. B., Chiarella, P., Rearte, M. B., Bustuoabad, O. D., Vermeulen, E. M., & Ruggiero, R. A. (2022). Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor. Web
Citación estilo ChicagoMontagna, Daniela Romina, Alejandra Beatriz Duarte, Paula Chiarella, María Bárbara Rearte, Oscar David Bustuoabad, Elba Monica Vermeulen, and Raul Alejandro Ruggiero. Inhibition of Hyperprogressive Cancer Disease Induced By Immune-checkpoint Blockade Upon Co-treatment With Meta-tyrosine and P38 Pathway Inhibitor. 2022.
Cita MLAMontagna, Daniela Romina, et al. Inhibition of Hyperprogressive Cancer Disease Induced By Immune-checkpoint Blockade Upon Co-treatment With Meta-tyrosine and P38 Pathway Inhibitor. 2022.